E-cigarette use declines among high school students, FDA and CDC say

E-cigarette use declines among high school students, FDA and CDC say


Elf Bar disposable vape flavored vaping e-cigarette products are displayed in a convenience store on June 23, 2022 in El Segundo, California. – Vaping company Juul Labs said Thursday it would appeal a decision by the US Food and Drug Administration ordering all its products off the market, a move the agency said was based on safety concerns. (Photo by Patrick T. FALLON / AFP) (Photo by PATRICK T. FALLON/AFP via Getty Images)

Patrick T. Fallon | Afp | Getty Images

E-cigarette usage among U.S. high school students has fallen as the government pursues aggressive action against companies selling illegal vape products that appeal to young people, federal health regulators said Thursday.

The findings, a part of the 2023 National Youth Tobacco Survey, showed that from 2022 to 2023 e-cigarette use among high school students declined to 10% from 14.1%, a drop representing about 580,000 fewer high schoolers.

The decline comes as overall tobacco smoking among this group hits an all-time low, according to the Food and Drug Administration and the Centers for Disease Control and Prevention. Current use of any tobacco product by high school students declined by an estimated 540,000 students, to 1.97 million in 2023 from 2.51 million in 2022.

“It’s encouraging to see this substantial decline in e-cigarette use among high schoolers within the past year, which is a win for public health,” Brian King, director of the FDA’s Center for Tobacco Products, said in a release.

E-cigarette usage has been the most commonly used tobacco product among both high school and middle school students for a decade. For middle schoolers, grades 6 to 8, there were no significant changes in e-cigarette use from 2022 to 2023. Still, for middle schoolers, there was an increase in current overall tobacco product use to 6.6% from 4.5%.

Curbing e-cigarette usage among the country’s youth has been a top priority for U.S. health regulators. In recent months, the issue has become more cumbersome as newer vaping devices flood the market from overseas and circumvent existing tobacco regulation. The biggest culprit, the Chinese brand Elf Bar, can still be found on shelves despite being banned by the FDA.

Among students currently using e-cigarettes, Elf Bar was the most commonly reported brand at 56.7%, followed by Esco Bars, Vuse, JUUL and Mr. Fog, the report found.

The report reiterated that youth use of tobacco products remains unsafe.

King said the agency has more work to do to crackdown as “bad actors place profit over the health of our nation’s youth.”

“The FDA remains concerned about youth tobacco product use, and we cannot and will not let our guard down on this issue,” King said. “The agency has an array of enforcement tools at our disposal, and we’re committed to using them as appropriate.”

Over the past year, the FDA said it has issued more than hundreds of warning letters to manufacturers, distributors and retailers of unauthorized e-cigarettes, including several distributors of Elf Bar.



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More